Skip to main content

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

An effectiveness and safety study of varenicline for smoking cessation in hospitalized patients with psychiatric disorders

IP: Eugeni Bruguera Cortada
Collaborators: -
Funding agency: Pfizer Inc
Funding: 90196.52
Reference: VARENICLINE_WI231379-PFIZER2017
Duration: 29/01/2018 - 01/04/2020

Related news

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

A project led by the Vall d’Hebron Research Institute (VHIR) in collaboration with FIDMAG Germanes Hospitalàries Research Foundation describes structural and functional brain changes in adolescents with borderline personality disorder (BPD).

A large-scale study involving Vall d’Hebron confirms the genetic relatedness among 14 different psychiatric disorders and groups them into five new families, paving the way for new treatments targeting their shared underlying genetic causes

Related professionals

Francisco Vidal Pérez

Francisco Vidal Pérez

Head of group
Transfusional Medicine
Read more
Mirjam Lukasse

Mirjam Lukasse

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Núria García Doladé

Núria García Doladé

Predoctoral researcher
Clinical Pharmacology
Read more
Diana Paola Mora Ramírez

Diana Paola Mora Ramírez

Predoctoral researcher
Ophtalmology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.